Acro Biomedical (ACBM) Current Assets (2015 - 2026)
Acro Biomedical (ACBM) posted Current Assets of $3648.0 for Q2 2026, down 74.12% on a QoQ basis from $14098.0 in Q4 2025, and down 90.79% year-over-year from $39626.0 in Q2 2025.
Powered by 
Analysis
Acro Biomedical (ACBM) Current Assets (2015 - 2026) Analysis & Trends
Acro Biomedical has reported Current Assets for 12 years, with the latest figure at $3648.0 in Q2 2026.
- On a quarterly basis, Current Assets fell 90.79% year-over-year to $3648.0 in Q2 2026; TTM through Jun 2026 was $3648.0, a 90.79% decrease from a year earlier, with the FY2025 full-year figure at $14098.0, up 177.74% from the prior year.
- Current Assets was $3648.0 for Q2 2026 at Acro Biomedical, down from $14098.0 in the prior quarter.
- The five-year high for Current Assets was $680018.0 in Q1 2022, with the low at $151.0 in Q1 2024.
- Average Current Assets over 5 years is $224889.6, with a median of $12501.0 recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Current Assets sank 99.98% in 2024, then surged 4179.27% in 2025.
- Over 5 years, Current Assets stood at $657537.0 in 2022, then tumbled by 99.75% to $1626.0 in 2023, then surged by 212.18% to $5076.0 in 2024, then jumped by 177.74% to $14098.0 in 2025, then slumped by 74.12% to $3648.0 in 2026.
- The last three Current Assets figures came in at $3648.0 (Q2 2026), $14098.0 (Q4 2025), and $4323.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 6.31 Bn |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 5.90 Bn |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 6.35 Bn |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 2.05 Bn |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | 431.48 Mn |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 2.45 Bn |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | 1.17 Bn |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 1.11 Bn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | 997,742.00 |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - | 3,648.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,648.00 |
| Dec 31, 2025 | 14,098.00 |
| Sep 30, 2025 | 4,323.00 |
| Jun 30, 2025 | 39,626.00 |
| Mar 31, 2025 | 4,851.00 |
| Dec 31, 2024 | 5,076.00 |
| Sep 30, 2024 | 701.00 |
| Jun 30, 2024 | 926.00 |
| Mar 31, 2024 | 151.00 |
| Dec 31, 2023 | 1,626.00 |
| Sep 30, 2023 | 12,501.00 |
| Jun 30, 2023 | 526,160.00 |
| Mar 31, 2023 | 637,552.00 |
| Dec 31, 2022 | 657,537.00 |
| Sep 30, 2022 | 607,428.00 |
| Jun 30, 2022 | 626,902.00 |
| Mar 31, 2022 | 680,018.00 |
| Dec 31, 2021 | 706,415.00 |
| Sep 30, 2021 | 623,560.00 |
| Jun 30, 2021 | 687,891.00 |